Summary

HNY Research projects that the Active Pharmaceutical Ingredients (API) market size will grow from 183.84 Million USD in 2025 to 290.66 Million USD by 2031, at an estimated CAGR of 7.93%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 45.46 Million USD, the Europe market size was 29.01 Million USD, and the Asia market size was 31.73 Million USD.
This report presents a detailed and holistic analysis of the global Active Pharmaceutical Ingredients (API) market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Active Pharmaceutical Ingredients (API) manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
Teva
Viatris
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Apeloa Pharmaceutical
NCPC
United Laboratories
Shandong Xinhua Pharmaceutical
CSPC
Harbin Pharmaceutical
LKPC

By Type
Synthetic APIs
Biotech APIs

By Application
Tablet
Injection
Capsule
Others

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Active Pharmaceutical Ingredients (API) Revenue
1.4 Market Analysis by Type
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type: 2026-2031
1.4.2 Synthetic APIs
1.4.3 Biotech APIs
1.5 Market by Application
1.5.1 Global Active Pharmaceutical Ingredients (API) Market Share by Application: 2026-2031
1.5.2 Tablet
1.5.3 Injection
1.5.4 Capsule
1.5.5 Others
1.6 Study Objectives
1.7 Overview of Global Active Pharmaceutical Ingredients (API) Market
1.7.1 Global Active Pharmaceutical Ingredients (API) Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API)
2.2 Industry Chain Structure of Active Pharmaceutical Ingredients (API)
3 Market Competition by Manufacturers
3.1 Global Active Pharmaceutical Ingredients (API) Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2020-2025)
4 Active Pharmaceutical Ingredients (API) Regional Market Analysis
4.1 Active Pharmaceutical Ingredients (API) Production by Regions
4.1.1 Global Active Pharmaceutical Ingredients (API) Production by Regions (2020-2025)
4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Regions
4.2 Active Pharmaceutical Ingredients (API) Consumption by Regions
4.3 North America Active Pharmaceutical Ingredients (API) Market Analysis
4.3.1 North America Active Pharmaceutical Ingredients (API) Production
4.3.2 North America Active Pharmaceutical Ingredients (API) Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Active Pharmaceutical Ingredients (API) Import and Export
4.4 East Asia Active Pharmaceutical Ingredients (API) Market Analysis
4.4.1 East Asia Active Pharmaceutical Ingredients (API) Production
4.4.2 East Asia Active Pharmaceutical Ingredients (API) Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Active Pharmaceutical Ingredients (API) Import & Export
4.5 Europe Active Pharmaceutical Ingredients (API) Market Analysis
4.5.1 Europe Active Pharmaceutical Ingredients (API) Production
4.5.2 Europe Active Pharmaceutical Ingredients (API) Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Active Pharmaceutical Ingredients (API) Import & Export
4.6 South Asia Active Pharmaceutical Ingredients (API) Market Analysis
4.6.1 South Asia Active Pharmaceutical Ingredients (API) Production
4.6.2 South Asia Active Pharmaceutical Ingredients (API) Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Active Pharmaceutical Ingredients (API) Import & Export
4.7 Southeast Asia Active Pharmaceutical Ingredients (API) Market Analysis
4.7.1 Southeast Asia Active Pharmaceutical Ingredients (API) Production
4.7.2 Southeast Asia Active Pharmaceutical Ingredients (API) Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Active Pharmaceutical Ingredients (API) Import & Export
4.8 Middle East Active Pharmaceutical Ingredients (API) Market Analysis
4.8.1 Middle East Active Pharmaceutical Ingredients (API) Production
4.8.2 Middle East Active Pharmaceutical Ingredients (API) Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Active Pharmaceutical Ingredients (API) Import & Export
4.9 Africa Active Pharmaceutical Ingredients (API) Market Analysis
4.9.1 Africa Active Pharmaceutical Ingredients (API) Production
4.9.2 Africa Active Pharmaceutical Ingredients (API) Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Active Pharmaceutical Ingredients (API) Import & Export
4.10 Oceania Active Pharmaceutical Ingredients (API) Market Analysis
4.10.1 Oceania Active Pharmaceutical Ingredients (API) Production
4.10.2 Oceania Active Pharmaceutical Ingredients (API) Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Active Pharmaceutical Ingredients (API) Import & Export
4.11 South America Active Pharmaceutical Ingredients (API) Market Analysis
4.11.1 South America Active Pharmaceutical Ingredients (API) Production
4.11.2 South America Active Pharmaceutical Ingredients (API) Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Active Pharmaceutical Ingredients (API) Import & Export
5 Active Pharmaceutical Ingredients (API) Sales Market by Type (2020-2031)
5.1 Global Active Pharmaceutical Ingredients (API) Historic Market Size by Type (2020-2025)
5.2 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Type (2026-2031)
6 Active Pharmaceutical Ingredients (API) Consumption Market by Application(2020-2031)
6.1 Global Active Pharmaceutical Ingredients (API) Historic Market Size by Application (2020-2025)
6.2 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Active Pharmaceutical Ingredients (API) Business
7.1 Teva
7.1.1 Teva Company Profile
7.1.2 Teva Active Pharmaceutical Ingredients (API) Product Specification
7.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Viatris
7.2.1 Viatris Company Profile
7.2.2 Viatris Active Pharmaceutical Ingredients (API) Product Specification
7.2.3 Viatris Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 DSM
7.3.1 DSM Company Profile
7.3.2 DSM Active Pharmaceutical Ingredients (API) Product Specification
7.3.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Company Profile
7.4.2 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Specification
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Aspen
7.5.1 Aspen Company Profile
7.5.2 Aspen Active Pharmaceutical Ingredients (API) Product Specification
7.5.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Novartis
7.6.1 Novartis Company Profile
7.6.2 Novartis Active Pharmaceutical Ingredients (API) Product Specification
7.6.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 BASF
7.7.1 BASF Company Profile
7.7.2 BASF Active Pharmaceutical Ingredients (API) Product Specification
7.7.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 Pfizer
7.8.1 Pfizer Company Profile
7.8.2 Pfizer Active Pharmaceutical Ingredients (API) Product Specification
7.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Company Profile
7.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Company Profile
7.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Company Profile
7.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Specification
7.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.12 Zhejiang Medicine
7.12.1 Zhejiang Medicine Company Profile
7.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Specification
7.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Company Profile
7.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Specification
7.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.14 Zhejiang NHU
7.14.1 Zhejiang NHU Company Profile
7.14.2 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Specification
7.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.15 Apeloa Pharmaceutical
7.15.1 Apeloa Pharmaceutical Company Profile
7.15.2 Apeloa Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
7.15.3 Apeloa Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.16 NCPC
7.16.1 NCPC Company Profile
7.16.2 NCPC Active Pharmaceutical Ingredients (API) Product Specification
7.16.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.17 United Laboratories
7.17.1 United Laboratories Company Profile
7.17.2 United Laboratories Active Pharmaceutical Ingredients (API) Product Specification
7.17.3 United Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.18 Shandong Xinhua Pharmaceutical
7.18.1 Shandong Xinhua Pharmaceutical Company Profile
7.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
7.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.19 CSPC
7.19.1 CSPC Company Profile
7.19.2 CSPC Active Pharmaceutical Ingredients (API) Product Specification
7.19.3 CSPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.20 Harbin Pharmaceutical
7.20.1 Harbin Pharmaceutical Company Profile
7.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification
7.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.21 LKPC
7.21.1 LKPC Company Profile
7.21.2 LKPC Active Pharmaceutical Ingredients (API) Product Specification
7.21.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) (2026-2031)
8.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) (2026-2031)
8.3 Global Forecasted Price of Active Pharmaceutical Ingredients (API) (2020-2031)
8.4 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Region (2026-2031)
8.4.1 North America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.3 Europe Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.7 Africa Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.9 South America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
9.2 East Asia Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
9.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Countriy
9.4 South Asia Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
9.5 Southeast Asia Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
9.6 Middle East Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
9.7 Africa Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
9.8 Oceania Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
9.9 South America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
9.10 Rest of the world Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer